15. Conclusion
Cancer patients are at an exceptionally high risk of developing SARS-CoV-2 infection and are also likely to have higher morbidity and mortality, prompting the need for special attention to be paid to this population. In general, three strategies can be undertaken to manage cancer patients during the COVID-19 pandemic: 1) delaying chemotherapy or elective surgeries in stable patients; 2) implementing strict personal precautions for every cancer patient; and 3) providing more intensive care and treatment to cancer patients infected with SARS-CoV-2. In brief, it is recommended that curative cancer treatment should be continued, despite the potential higher risk of being infected with SARS-CoV-2 during anticancer therapy. Nevertheless, surgeries may be postponed based on the clinicians’ judgment, and this at-risk population should be prioritized in the vaccination program.